Mirabella Financial Services LLP Takes Position in Cardlytics, Inc. (NASDAQ:CDLX)

Mirabella Financial Services LLP purchased a new position in Cardlytics, Inc. (NASDAQ:CDLX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,155,000 shares of the company's stock, valued at approximately $4,285,000. Mirabella Financial Services LLP owned 2.27% of Cardlytics as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. Rangeley Capital LLC bought a new position in Cardlytics in the 4th quarter worth about $1,187,000. Natixis bought a new position in shares of Cardlytics in the fourth quarter worth approximately $462,000. Geode Capital Management LLC raised its stake in Cardlytics by 7.5% in the third quarter. Geode Capital Management LLC now owns 1,053,178 shares of the company's stock valued at $3,371,000 after purchasing an additional 73,484 shares in the last quarter. XTX Topco Ltd bought a new stake in Cardlytics during the fourth quarter valued at approximately $157,000. Finally, Barclays PLC grew its stake in Cardlytics by 223.9% in the 3rd quarter. Barclays PLC now owns 58,026 shares of the company's stock worth $186,000 after buying an additional 40,112 shares in the last quarter. Hedge funds and other institutional investors own 68.10% of the company's stock.

Insider Activity at Cardlytics

In other Cardlytics news, CEO Amit Gupta sold 46,857 shares of Cardlytics stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total transaction of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares of the company's stock, valued at approximately $1,423,365.80. The trade was a 10.07 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Alexis Desieno sold 24,778 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total value of $84,245.20. Following the transaction, the chief financial officer now owns 140,948 shares in the company, valued at $479,223.20. This trade represents a 14.95 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 75,315 shares of company stock worth $254,789 over the last quarter. 4.40% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CDLX has been the topic of several research reports. Evercore ISI lowered their price objective on shares of Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a research report on Thursday, March 13th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cardlytics in a research note on Thursday, March 13th. Finally, Lake Street Capital reduced their price objective on Cardlytics from $5.00 to $3.00 and set a "hold" rating on the stock in a research note on Thursday, March 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Cardlytics presently has a consensus rating of "Hold" and an average target price of $6.42.

Cardlytics Trading Down 5.3 %

CDLX traded down $0.09 during midday trading on Friday, reaching $1.53. 415,649 shares of the company's stock traded hands, compared to its average volume of 1,009,452. Cardlytics, Inc. has a 52 week low of $1.22 and a 52 week high of $15.89. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The firm has a fifty day moving average of $2.03 and a two-hundred day moving average of $3.12. The stock has a market capitalization of $79.43 million, a price-to-earnings ratio of -0.25 and a beta of 1.39.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.